T1000	Speculation 1494 1497	may
E1000	Speculation:T1000 Scope:T1001
T1001	Span 1494 1681	may be a patient selection biomarker when determining the most efficacious treatment modality for these different subsets of patients (e.g., inclusion or exclusion of epigenetic therapies
T1002	Negation 160 163	not
E1001	Negation:T1002 Scope:T1003
T1003	Span 160 170	not SLC5A8
T1004	Speculation 1897 1902	might
E1002	Speculation:T1004 Scope:T1005
T1005	Span 1897 1969	might help guide adjunctive inclusion or exclusion or epigenetic therapy
